One day after his administration “found an answer to autism,” President Trump announced a new effort to warn the Americans on Monday that the use of Tylenol and other acetaminophen-based painkillers during pregnancy can be associated with a neurological condition and encourage him to use leukroinine, lesser known cancer and anemia.
However, both theories are unproven, and Trump has not provided any new evidence to support its new recommendations of his administration.
“I have always had very strong feelings about autism and how it happened and where it came from,” the president said. “We understood many more than many people who studied it.”
After January Returned to the Oval Office, Trump repeatedly undertook to address the increasing level of American autism. April Robert F. Kennedy Jr., Secretary of Health and Human Services, who has long advertising theories about the disorder, said the administration “has launched a huge testing and research effort to include hundreds of scientists from around the world,” promising “we will know what caused the autism epidemic by September.
On Monday, Kennedy fulfilled this promise. Instead, he said the national health institutes would continue to examine the “multimedia” hypotheses about potential causes and that 13 research grants will be launched this month, and the updates are likely to be next year.
However, short and Kennedy, along with other administrative officials, claimed that the prenatal effect of acetaminophen, the active Tylenol ingredient and one of the most widely used medicines around the world could increase the risk of autism spectrum disorder (ASD), and that the food and medicine administration made a new recommendation to take pregnant people only.
Officials also emphasized studies showing that phorinic acid (form of vitamin B9), also known as leukovorin-year old medicine, which is often prescribed to neutralize a certain anticancer on cancer to help strengthen communication and cognition at least some people with autism.
During Monday’s report, Kennedy continued his efforts to associate children’s vaccines with autism, a statement that was thoroughly lifted. In calling ASD as “a complex disorder”, he said he would not be “taboo” in future research. “One area we are looking at carefully is vaccines,” Kennedy said. “Scientists will look honestly at this topic. We’ll look for answers.
The remaining Monday’s report was not based on similar discredited sciences. However, experts also do not consider it a “response to autism.”
What do we know about Tylenol and autism
Recent studies have made contradictory conclusions about acetaminophen. August BMC Environmental Health has published an overview of existing studies, including six studies on the use of prenatal acetaminophen and in children’s ASD risking aimed at finding “strong evidence of the drug to disorder relationship.”
The article was followed by dr. Andrea Baccarelli, Dean of the Harvard Chan School of Public Health, and finally recommended “the reasonable use of acetaminophen-the lowest effective dose, the shortest duration-the Medicine Aid Service, adapted for individual risk and beneficial assessments.”
Still, the big 2024. A study investigating nearly 2.5 million people born in Sweden in 1995-2019 terminated that “acetaminophen use during pregnancy was not associated with the risk of pediatric autism.”
Why the difference? Like other researchers, the Swedish team found the increased prevalence of autism among people who used acetaminophen during pregnancy. However, according to their study, the risk was only slightly higher-and later, 9 percentage points-and it disappeared when they were zero, the cases of siblings, when one of the parents used acetaminophen in one pregnancy rather than another.
“This shows that what initially seemed to have an increased risk of acetaminophen autism during pregnancy may have been due to other risk factors,” the scientific American recently explained: “Feren or major infections were used to treat silenol.” (In a 2014 study involving more than 2 million people, it was found that if the pregnant person was admitted to hospital infection, the likelihood of their child’s development of autism will increase by approximately 30%).
“The conditions that humans use acetaminophen during pregnancy are much more dangerous than any theoretical risk and can cause severe morbidity and mortality to the pregnant person and the fetus,” the American College of Obstetricians and Gynecologists said in a statement.
What do we know about leukovorin and autism
Meanwhile, Leucovorin has shown the promise as a possible treatment of autism, but it is too early to draw any final conclusions about its effectiveness.
Scientists have long known that folate deficiency during pregnancy could increase the risk of nerve pipe defects. (Neuronal tube eventually develops into the brain and spinal cord.) A study found that some children with autism symptoms have a condition that makes it harder for their body to transport folate to their brain. As a result, researchers of Arizona, France, China, India and Iran have performed small, random sample -controlled folic acid studies as a treatment for autism – ie as a way to help bring folate more effectively – and everyone has found modest improvements in acceptable and expressive speeches.
However, only a few dozen children have been involved in each of these studies, while the larger Leucovorin attempts were launched slowly as their primary patents ended (leaving pharmaceutical companies with little incentives to finance further research).
Contradictory claims
Monday’s announcement is likely to be controversial in the autism community. ASD diagnoses have increased by about 300% over the last 20 years, which is a shift, mainly attributed to environmental factors.
“There is something artificial,” he said Monday. – They take something.
On the contrary, half of the studies show that ASD is a “complex neurodegenerative condition resulting from genetic factors and constellations of the environment,” as scientific American said, and most public health officials attribute increasing norms to a broader definition of disorder-generation with increased selection and understanding.
Thus, while the promise for exceptional reasons and silver bullets may point out, experts warn that opposing science can deny families.
“The press release, which talks about the potential association, will cause a lot of fear,” dr. Debra Houry, a former chief medical officer of the Centers for Disease Control and Prevention. “If there is no science to support it, we will see changes in practice, worried moms, all kinds of things, and it is not appropriate.”